Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of XBIO will rise by +5.47% over the next 2 Weeks and hit $3.20 by Thursday, May 14, 2026. In that time frame, XBIO's share price is expected to range between $2.93 and $3.47.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 14, 2026 | 2.93 | 3.20 | 3.47 |
| May 13, 2026 | 2.85 | 3.12 | 3.40 |
| May 12, 2026 | 2.83 | 3.12 | 3.39 |
| May 11, 2026 | 2.86 | 3.13 | 3.42 |
| May 8, 2026 | 2.93 | 3.18 | 3.46 |
| May 7, 2026 | 2.84 | 3.12 | 3.38 |
| May 6, 2026 | 2.78 | 3.05 | 3.33 |
| May 5, 2026 | 2.78 | 3.05 | 3.31 |
| May 4, 2026 | 2.78 | 3.06 | 3.34 |
| May 1, 2026 | 2.84 | 3.11 | 3.39 |
XBIO shares fell -1.98% in Friday, May 1, 2026's trading session, dropping from a previous close of $3.03 to move at $2.97. The stock demonstrated notable intraday movement (see XBIO's key stats for a full breakdown), fluctuating between $2.95 and $2.99, a +1.36% trading range. While recent weeks have seen some volatility, XBIO has managed to secure a -16.57% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 4.2K shares changing hands, 1.63K fewer than the previous session. This amounted to $12.47K in total market activity.
Will XBIO Continue Its Upward Trend?
According to analyst ratings and projections for XBIO, Xenetic Biosciences, Inc. shares are anticipated to increase by +14.39%, potentially reaching $3.47 per share by May 14, 2026. Short-term technical indicators currently suggest a neutral sentiment for XBIO. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 13 positive trading days within the past 30 sessions. Based on the XBIO stock forecast, now is a good time to buy XBIO stock because its current trading price is -7.06% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on XBIO covering social and institutional perspectives.
XBIO Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into XBIO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 40.91% to 49.60%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 51.18%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 50.15%, maintains a neutral outlook for the long term. Insights into XBIO's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Xenetic Biosciences Short-Term Forecasts
XBIO Forecast For Next 5 Days
Our algorithm anticipates Xenetic Biosciences (XBIO) stock could hit $3.07 by May 08, 2026. This represents a +3.44% rise from today's price, following a +8.89% change over the past five days.
XBIO Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Xenetic Biosciences, Inc. (XBIO) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $3.25, which would mean a +9.43% increase from the current price of $2.97. Projections for this period range from a high of $3.88 to a low of $2.81.
XBIO Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Xenetic Biosciences's price over the next three months point to a rise. XBIO stock is expected to peak at $10.94 on Jul 31, 2026 after potentially dipping to $7.56 on May 15, 2026. On average, XBIO is likely to trade around $9.17 in the coming 90 days.
Xenetic Biosciences Stock Forecast 2025
Based on our predictive models, Xenetic Biosciences (XBIO) is expected to trade between $5.26 and $11.60 throughout 2026. This would result in an average price of $9.41, potentially offering investors a +216.84% return from current levels.
Xenetic Biosciences, Inc. Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, Xenetic Biosciences, Inc. (XBIO) is positioned to show a strong performance in May 2026. The price is predicted to move between $7.56 and $9.29, settling at an average of $8.38. This could translate to a +182.15% gain.
June 2026
Based on current market signals, Xenetic Biosciences, Inc. is projected to trend june 2026. We forecast a trading range from $8.71 to $9.71, with a likely average price of $9.25. Investors could expect a potential return of +211.45%.
July 2026
Our predictive algorithms indicate Xenetic Biosciences, Inc. stock may see a shift in July 2026. The expected range spans $8.95–$10.94, with an average target of $9.79. This represents a positive outlook and a possible gain of +229.63%.
August 2026
Analyzing established trends, Xenetic Biosciences, Inc. looks set to move in August 2026. Projections place the stock between $9.63 and $11.48, averaging around $10.68. This suggests a +259.60% gain from current levels.
September 2026
Market indicators suggest Xenetic Biosciences, Inc. could experience notable changes during September 2026. Prices could fluctuate within $9.63 to $11.60, with a midpoint forecast of $10.74. The stock might deliver a +261.62% gain.
October 2026
Forecasting for October 2026, models estimate that Xenetic Biosciences, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $7.63 and $11.48, averaging $10.31. This signals a positive trajectory with potential returns around +247.14%.
November 2026
According to our latest forecast models, Xenetic Biosciences, Inc. (XBIO) is positioned to show a strong performance in November 2026. The price is predicted to move between $6.20 and $9.83, settling at an average of $8.34. This could translate to a +180.81% gain.
December 2026
Based on current market signals, Xenetic Biosciences, Inc. is projected to trend december 2026. We forecast a trading range from $5.26 to $9.68, with a likely average price of $7.72. Investors could expect a potential return of +159.93%.
January 2027
Our predictive algorithms indicate Xenetic Biosciences, Inc. stock may see a shift in January 2027. The expected range spans $5.04–$10.19, with an average target of $8.90. This represents a positive outlook and a possible gain of +199.66%.
February 2027
Analyzing established trends, Xenetic Biosciences, Inc. looks set to move in February 2027. Projections place the stock between $4.30 and $9.25, averaging around $8.10. This suggests a +172.73% gain from current levels.
March 2027
Market indicators suggest Xenetic Biosciences, Inc. could experience notable changes during March 2027. Prices could fluctuate within $3.62 to $9.47, with a midpoint forecast of $7.94. The stock might deliver a +167.34% gain.
April 2027
Forecasting for April 2027, models estimate that Xenetic Biosciences, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $2.52 and $9.51, averaging $7.87. This signals a positive trajectory with potential returns around +164.98%.
XBIO's history of dividends and stock splits also plays a role in long-term investor confidence.

